Science Strategic Acquisition Alpha Corp (SSAA) Financials
$10.05
$0.00 (0.00%)As on 21-Dec-2022 09:30EDT
Market cap
$390 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
25.1
P/B Ratio
1.3
Div. Yield
0 %
Income Statement ($ Mln) |
TTM | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 | Dec-12 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Cost of Revenue
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Gross Profit
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Operating Expenses
|
319.97
|
2.95
|
--
|
--
|
--
|
--
|
|||||
|
Operating Profit (EBIT)
|
-2,948.40
|
-2,947.22
|
--
|
--
|
--
|
--
|
|||||
|
Other Income
|
7.12
|
3.11
|
--
|
--
|
--
|
--
|
|||||
|
Profit before Tax
|
167.08
|
158.78
|
--
|
--
|
--
|
--
|
|||||
|
Provision for Tax
|
0.30
|
0.00
|
--
|
--
|
--
|
--
|
|||||
|
Profit after Tax (Net Income)
|
166.78
|
158.78
|
--
|
--
|
--
|
--
|
|||||
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Consolidated Profit
|
9.96
|
0.32
|
-0.03
|
--
|
--
|
--
|
Liabilities ($ Mln) |
TTM | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 | Dec-12 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
-12.47
|
-20.29
|
0.02
|
--
|
--
|
--
|
|||||
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Non-Current Liabilities
|
11.66
|
19.41
|
--
|
--
|
--
|
--
|
|||||
|
Current Liabilities
|
2.71
|
1.64
|
183.91
|
--
|
--
|
--
|
|||||
|
Total Liabilities
|
4.61
|
311.26
|
203.91
|
--
|
--
|
--
|
Cashflow ($ Mln) |
TTM | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 | Dec-12 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
-1,330.64
|
-1.33
|
--
|
--
|
--
|
|||||
|
Cash Flow from Investing Activities
|
--
|
-310.50
|
-310.50
|
--
|
--
|
--
|
|||||
|
Cash from Financing Activities
|
--
|
312,156.96
|
0.12
|
--
|
--
|
--
|
|||||
|
Net Cash Inflow / Outflow
|
--
|
0.33
|
--
|
--
|
--
|
--
|
Financials Ratios |
TTM | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 | Dec-12 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS ($)
|
20.85
|
19.85
|
--
|
--
|
--
|
--
|
|||||
|
Cash EPS ($)
|
--
|
19.85
|
--
|
--
|
--
|
--
|
|||||
|
Adjusted Book Value ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Dividend per Share ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Cash Flow per Share ($)
|
--
|
-166.33
|
--
|
--
|
--
|
--
|
|||||
|
Free Cash Flow per Share ($)
|
--
|
-166.33
|
--
|
--
|
--
|
--
|
Profitability Ratios |
TTM | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 | Dec-12 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
-1,566.46
|
--
|
--
|
--
|
--
|
|||||
|
ROE (%)
|
--
|
-1,566.46
|
--
|
--
|
--
|
--
|
|||||
|
ROA (%)
|
35.58
|
61.64
|
--
|
--
|
--
|
--
|
|||||
|
EBIT Margin (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Net Margin (%)
|
2,340.98
|
5,111.89
|
--
|
--
|
--
|
--
|
|||||
|
Cash Profit Margin (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
Growth Ratios |
TTM | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 | Dec-12 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
EBIT Growth (%)
|
--
|
629.25
|
--
|
--
|
--
|
--
|
|||||
|
Net Profit Growth (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
EPS Growth (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Book Value Growth (%)
|
43.16
|
--
|
--
|
--
|
--
|
--
|
Valuation Ratios |
TTM | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 | Dec-12 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
25.13
|
0.49
|
--
|
--
|
--
|
--
|
|||||
|
Price / Book Value
|
1.31
|
-3.84
|
--
|
--
|
--
|
--
|
|||||
|
Dividend Yield (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
EV/EBITDA
|
-161.51
|
0.49
|
--
|
--
|
--
|
--
|
|||||
|
Close Price ($)
|
9.86
|
9.75
|
--
|
--
|
--
|
--
|
|||||
|
High Price ($)
|
9.90
|
10.20
|
--
|
--
|
--
|
--
|
|||||
|
Low Price ($)
|
9.70
|
9.60
|
--
|
--
|
--
|
--
|
|||||
|
Market Cap ($ Cr)
|
390.07
|
--
|
--
|
--
|
--
|
--
|
Solvency Ratios |
TTM | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 | Dec-12 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Short term debt to equity ratio
|
-0.06
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Current Ratio
|
0.21
|
0.42
|
0.00
|
--
|
--
|
--
|
|||||
|
Quick Ratio
|
0.21
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Interest Coverage
|
--
|
--
|
--
|
--
|
--
|
--
|
Operating Efficiency Ratios |
TTM | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 | Dec-12 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Asset Turnover
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Receivable days
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Inventory Days
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Payable days
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Cash Conversion Cycle
|
--
|
--
|
--
|
--
|
--
|
--
|